Cargando…
Liver transplantation for pediatric inherited metabolic liver diseases
Liver transplantation (LT) remains the gold standard treatment for end stage liver disease in the pediatric population. For liver based metabolic disorders (LBMDs), the decision for LT is predicated on a different set of paradigms. With improved outcomes post-transplantation, LT is no longer merely...
Autores principales: | Vimalesvaran, Sunitha, Dhawan, Anil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568579/ https://www.ncbi.nlm.nih.gov/pubmed/34786171 http://dx.doi.org/10.4254/wjh.v13.i10.1351 |
Ejemplares similares
-
Cellular Therapies in Pediatric Liver Diseases
por: Vimalesvaran, Sunitha, et al.
Publicado: (2022) -
Epidemiology, Risk Factors and Outcome Due to Multidrug Resistant Organisms in Paediatric Liver Transplant Patients in the Era of Antimicrobial Stewardship and Screening
por: Verma, Anita, et al.
Publicado: (2022) -
Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
por: Gill, Madeleine G, et al.
Publicado: (2020) -
De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
por: Han, Ma Ai Thanda, et al.
Publicado: (2021) -
Liver transplantation for benign liver tumors
por: Ostojic, Ana, et al.
Publicado: (2021)